ASSEMBLY BIOSCIENCES, INC. — Revenue by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ab387b8d-4691-41c4-834b-1e412ae7aabe/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $72.3M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-115992 |
| FY 2024 | $28.5M | 2024-01-01 – 2024-12-31 | evidence 0001193125-26-115992 |
| FY 2023 | $7.2M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-038057 |
| FY 2022 | $0 | 2022-01-01 – 2022-12-31 | evidence 0000950170-24-038057 |
| FY 2021 | $6.3M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-009855 |
| FY 2020 | $79.1M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-008878 |
| FY 2019 | $16.0M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-008696 |
| FY 2018 | $14.8M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-011361 |
| FY 2017 | $9.0M | 2017-01-01 – 2017-12-31 | evidence 0001144204-19-011361 |
| FY 2016 | $0 | 2016-01-01 – 2016-12-31 | evidence 0001144204-19-011361 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ASSEMBLY BIOSCIENCES, INC. — all facts · Net Income · Operating Income